Q4 2020 Catalyst Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Catalyst Pharmaceuticals Fourth Quarter and Fiscal Year 2020 Financial Results Conference Call.
(Operator Instructions)
As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Ali Grande, Chief Financial Officer. Thank you. Please go ahead.
Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's fourth quarter and full year 2020 financial results and corporate highlights. Speakers on today's call, we have Patrick McEnany, Chairman and Chief Executive Officer; Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer; and Jeffrey Del Carmen, Chief Commercial Officer. Joining the Q&A we'll also have Mr. Gary Ingenito, Chief Medical and Regulatory Officer.
Before we begin, I would like to remind you that in the following comments and in the Q&A session, we will make statements about expected future results, which may be forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |